Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This proposal aims to systematically examine the safety and pharmacokinetic/pharmacodynamic
profile and the physiologic, neuroendocrine and behavioral stress and pain responses to acute
single doses and repeated dosing of oral tablet formulation of natural Cannabidiol (CBD)
alone and in combination with Tetrahydrocannabinol and matched Placebo (PLA).